← FDA Drug Approvals (Drugs@FDA)
REMIFENTANIL HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NIVAGEN PHARMS INC · Approved 2024-06-28
Drug application
- FDA Application #
ANDA215635- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- REMIFENTANIL HYDROCHLORIDE
- Generic name
- Remifentanil Hydrochloride
- Active ingredients
- REMIFENTANIL HYDROCHLORIDE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- NIVAGEN PHARMS INC
- First approval
- 2024-06-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown